ABOUT THE MEETING

The ASCP Annual Meeting is the premier meeting each year in the field of psychopharmacology. Bringing together representatives from academia, the National Institutes of Health (NIH), Food and Drug Administration (FDA), European regulatory agencies, and industry to discuss key aspects of neuropsychiatric drug development, including the impact of diagnostic changes and personalized interventions based on biomarkers or genetic information. A Program Committee for the Annual Meeting chaired by Drs. Mark Rapaport and Tiffany Farchione including representatives from the ASCP Community, FDA, EMA, NIMH, NIDA, NIAAA, and the academia members, lead the direction of the meeting. The Review Subcommittee, under the leadership of Drs. Manish Jha and Carlos Blanco, are responsible for the review of all program submissions. To ensure the meeting includes the needs of our loyal pharmaceutical industry members, we are excited to announce the launch of the ASCP Industry Advisory Council led by Drs. Ross Baker and Julie Adams.

The ASCP Annual Meeting brings together over 900 academic and industry investigators, research pharmacists, and clinicians, including competitively selected New Investigator Awardees.  ASCP is joined by federal partners, the National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA), National Institute on Alcohol Abuse and Alcoholism, (NIAAA) and the Food and Drug Administration (FDA) to organize a program that emphasizes the presentation of information that has not been previously published or presented. For more information about the history and purpose of the ASCP Annual Meeting please click here.

In recent years, the ASCP Annual Meeting focus has been expanded to address a number of timely issues relevant to clinical research in psychiatry, including the translation of research into practice, the importance of regulatory issues, and pharmacogenetics and other means to personalizing interventions.
 

ASCP 2025 Abstract Book
ASCP 2025 Program Book
ANNUAL MEETING WEBSITE

PAST ASCP ANNUAL MEETINGS

do not use

Please click on the links below to access virtual copies of pertinent meeting documents:

Presentation Slides are Available for the Below Sessions:

Regulatory Plenary: GLP-1 Agonists and Neuropsychiatric Disorders

ASCP Lifetime Awardee Talk

ASCP Award for Excellence in Clincial Psychopharmacology Education Talk

Clinical Updates in Neurotherapeutics

    Keynote Plenary

    Update From Federal and Other Funding Agencies Plenary

      2025 ASCP Annual Meeting: May 27 - May 30, 2025

      Please click on the links below to access virtual copies of pertinent meeting documents:

      Presentation Slides are Available for the Below Sessions:

      Regulatory Plenary: GLP-1 Agonists and Neuropsychiatric Disorders

      ASCP Lifetime Awardee Talk

      ASCP Award for Excellence in Clincial Psychopharmacology Education Talk

      Clinical Updates in Neurotherapeutics

      Keynote Plenary

      Update From Federal and Other Funding Agencies Plenary

        2024 ASCP Annual Meeting: May 28 - May 31, 2024

        Please click on the links below to access virtual copies of pertinent meeting documents:

        2023 ASCP Annual Meeting: May 30 - June 02, 2023

        Please click on the links below to access virtual copies of pertinent meeting documents:

        Presentation Slides are Available for the Below Sessions:

        Regulatory Plenary: Pediatric Drug Development in Psychiatry

        ASCP Lifetime Awardee Talk

        Clinical Updates in Neurotherapeutics

        Keynote Plenary: The Changing Landscape of Clinical Psychiatry: Novel Therapeutics, Methods and Assessments

        Update From Federal and Other Funding Agencies Plenary

        2022 ASCP Annual Meeting: May 31 - June 03, 2022

        "Reassessing Research and Clinical Practice in the Peri-pandemic Era"
        Fairmont Scottsdale Princess | Scottsdale, Arizona

        Presentation Slides are Available for the Below Sessions:

        Lifetime Awardee: Looking Back, Giving Thanks, and Moving Forward: Reflections on 50 Years as Physician/Scientist/Mentor in Geriatric Psychiatry

        Clinical Updates in Psychopharmacology Session

          Update from Federal and Other Funding Agencies

          Regulatory Plenary

          2021 ASCP Annual Meeting: June 01 - 04, 2021

          Live Internet Course
          Virtual

          Lifetime Awardee: Adventures in Wonderland: The Circuitous Route from Stage and Screen through Decades in Academia to Digital Health Startup

          Clinical Updates in Psychopharmacology Session

          Keynote Plenary Session: Integrating New and Novel Treatments into Clinical Practice

          Federal Agency Updates Plenary

          Regulatory Plenary

          2020 ASCP Annual Meeting: May 29 - 30, 2020

          Live Internet Course
          Virtual

            2019 ASCP Annual Meeting: May 28 - 31, 2019

            “Innovations in Personalized Medicine: From Biomarkers to Patient-Centered-Care”
            Fairmont Scottsdale Princess, Scottsdale, Arizona

            2018 ASCP Annual Meeting: May 29 - June 01, 2018

            “Treatment of Psychiatric Illness Across the Lifespan”
            Loews Miami Beach, Miami Beach, Florida

            2017 ASCP Annual Meeting: May 29 - June 02, 2017

            “Serving the Needs of the Diverse Population”
            Loews Miami Beach, Miami Beach, Florida

            2016 ASCP Annual Meeting: May 30 - June 03, 2016

            “Anticipating Future Interventions: Discovering New Targets, Integrative Biomarkers, and Beyond”
            Fairmont Scottsdale Princess, Scottsdale, Arizona

            2015 ASCP Annual Meeting: June 22 - 25, 2015

            “Staging Illness and Treatment:  From Prevention to Recovery”
            Loews Miami Beach Hotel, Miami, Florida

            2014 ASCP Annual Meeting (Formerly NCDEU): June 16 - 19, 2014

            “New Approaches to Mental Illness in the Era of the National Brain Initiative”
            Westin Diplomat, Hollywood, Florida

            2013 – 53rd NCDEU: An Annual Meeting Sponsored by ASCP: May 28 - 31, 2013

            “Recognizing Unmet Needs in Psychopharmacology: From Biomarkers to Breakthrough Therapies”
            Westin Diplomat, Hollywood Florida

            2012 – 52nd NCDEU Meeting: An Annual Meeting Sponsored by ASCP: May 29 - June 01, 2012

            “Identifying Common Targets across Brain Diseases – Implications for Treatment, Development and Delivery”
             Arizona Biltmore Resort & Spa, Scottsdale, Arizona

            2011 – 51st NCDEU Meeting: An Annual Meeting Sponsored by ASCP: June 13 - 16, 2011

            “Anticipating the Future of Drug Development:  New Targets, Integrative Biomarkers, and Beyond”
            Boca Raton Resort & Club, Boca Raton, Florida